Role of p53, Bax, p21, and DNA-PKcs in radiation sensitivity of HCT-116 cells and xenografts

Surgery (United States)

Volumn 154, Issue 2, 2013, Pages 143-151

  Huerta, Sergio ^a   Gao, Xiaohuan ^a   Dineen, Sean ^a   Kapur, Payal ^a   Saha, Debrabata ^b   Meyer, Jeffrey ^b  

^a UNIVERSITY OF TEXAS AT DALLAS   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOPTOSIS INDUCING FACTOR; PROTEIN BAX; PROTEIN P21; PROTEIN P53; SMALL INTERFERING RNA; VASCULOTROPIN;

ARTICLE; CAPILLARY DENSITY; CELL GROWTH; CELL STRAIN HCT116; CELL SURVIVAL; COLORECTAL CANCER; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; IONIZING RADIATION; PHENOTYPE; PRIORITY JOURNAL; RADIOSENSITIVITY; TREATMENT RESPONSE; TUMOR NECROSIS; TUMOR XENOGRAFT;

ANIMALS; APOPTOSIS INDUCING FACTOR; BCL-2-ASSOCIATED X PROTEIN; COLORECTAL NEOPLASMS; CYCLIN-DEPENDENT KINASE INHIBITOR P21; DNA-ACTIVATED PROTEIN KINASE; HCT116 CELLS; HUMANS; MICE; RADIATION TOLERANCE; TUMOR SUPPRESSOR PROTEIN P53; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84880867961     PISSN: 00396060     EISSN: 15327361     Source Type: Journal    
DOI: 10.1016/j.surg.2013.03.012     Document Type: Article

References (20)

1. S. Huerta, J. Hrom, X. Gao, D. Saha, T. Anthony, and H. Reinhart Tissue microarray constructs to predict a response to chemoradiation in rectal cancer Dig Liver Dis 42 2010 679 684
2. M. Maas, P.J. Nelemans, V. Valentini, P. Das, C. Rodel, and L.J. Kuo Long-term outcome in patients with a pathological complete response after chemoradiation for rectal cancer: a pooled analysis of individual patient data Lancet Oncol 11 2010 835 844
3. R.S. Dalton, R. Velineni, M.E. Osborne, R. Thomas, S. Harries, and A.S. Gee A single-centre experience of chemoradiotherapy for rectal cancer: is there potential for nonoperative management? Colorectal Dis 14 2012 567 571
4. A. Habr-Gama, R.O. Perez, W. Nadalin, J. Sabbaga, U. Ribeiro Jr., and A.H. Silva e Sousa Jr. Operative versus nonoperative treatment for stage 0 distal rectal cancer following chemoradiation therapy: long-term results Ann Surg 240 2004 711 717
5. M. Maas, R.G. Beets-Tan, D.M. Lambregts, G. Lammering, P.J. Nelemans, and S.M. Engelen Wait-and-see policy for clinical complete responders after chemoradiation for rectal cancer J Clin Oncol 29 2011 4633 4640
6. J.D. Smith, J.A. Ruby, K.A. Goodman, L.B. Saltz, J.G. Guillem, and M.R. Weiser Nonoperative management of rectal cancer with complete clinical response after neoadjuvant therapy Ann Surg 256 2012 965 972
7. J.G. Kuremsky, J.E. Tepper, and H.L. McLeod Biomarkers for response to neoadjuvant chemoradiation for rectal cancer Int J Radiat Oncol Biol Phys 74 2009 673 688
8. S. Huerta, X. Gao, and D. Saha Mechanisms of resistance to ionizing radiation in rectal cancer Expert Rev Mol Diagn 9 2009 469 480
9. H. Tian, E.K. Wittmack, and T.J. Jorgensen p21WAF1/CIP1 antisense therapy radiosensitizes human colon cancer by converting growth arrest to apoptosis Cancer Res 60 2000 679 684 (Pubitemid 30094567)
10. T. Cook, Z. Wang, S. Alber, K. Liu, S.C. Watkins, and Y. Vodovotz Nitric oxide and ionizing radiation synergistically promote apoptosis and growth inhibition of cancer by activating p53 Cancer Res 64 2004 8015 8021 (Pubitemid 39446937)
11. X. Gao, D. Saha, P. Kapur, T. Anthony, E.H. Livingston, and S. Huerta Radiosensitization of HT-29 cells and xenografts by the nitric oxide donor DETANONOate J Surg Oncol 100 2009 149 158
12. D. Shibata, M.A. Peinado, Y. Ionov, S. Malkhosyan, and M. Perucho Genomic instability in repeated sequences is an early somatic event in colorectal tumorigenesis that persists after transformation Nat Genet 6 1994 273 281 (Pubitemid 24188625)
13. B.L. Ruis, K.R. Fattah, and E.A. Hendrickson The catalytic subunit of DNA-dependent protein kinase regulates proliferation, telomere length, and genomic stability in human somatic cells Mol Cell Biol 28 2008 6182 6195
14. S. Huerta, X. Gao, and D. Saha Murine orthotopic model for the assessment of chemoradiotherapeutic interventions in rectal cancer Anticancer Drugs 22 2011 371 376
15. Y. Zhao, H.D. Thomas, M.A. Batey, I.G. Cowell, C.J. Richardson, and R.J. Griffin Preclinical evaluation of a potent novel DNA-dependent protein kinase inhibitor NU7441 Cancer Res 66 2006 5354 5362 (Pubitemid 43844961)
16. S. Huerta, E.J. Goulet, S. Huerta-Yepez, and E.H. Livingston Screening and detection of apoptosis J Surg Res 139 2007 143 156 (Pubitemid 46482558)
17. C. Wagener, R.C. Bargou, P.T. Daniel, K. Bommert, M.Y. Mapara, and H.D. Royer Induction of the death-promoting gene bax-alpha sensitizes cultured breast-cancer cells to drug-induced apoptosis Int J Cancer 67 1996 138 141 (Pubitemid 26236080)
18. H. Yamaguchi, K. Bhalla, and H.G. Wang Bax plays a pivotal role in thapsigargin-induced apoptosis of human colon cancer HCT116 cells by controlling Smac/Diablo and Omi/HtrA2 release from mitochondria Cancer Res 63 2003 1483 1489 (Pubitemid 36373633)
19. L. Zhang, J. Yu, B.H. Park, K.W. Kinzler, and B. Vogelstein Role of BAX in the apoptotic response to anticancer agents Science 290 2000 989 992
20. H.J. Chang, K.H. Jung, D.Y. Kim, S.Y. Jeong, H.S. Choi, and Y.H. Kim Bax, a predictive marker for therapeutic response to preoperative chemoradiotherapy in patients with rectal carcinoma Hum Pathol 36 2005 364 371 (Pubitemid 40591806)